Clinical Edge Journal Scan

Understanding the bidirectional causal link between Crohn’s disease and PsA


 

Key clinical point: Psoriatic arthritis (PsA) was positively associated with Crohn’s disease and genetically predicted Crohn’s disease was associated with an increased risk for PsA, indicating a bidirectional causal relationship between the 2 diseases.

Major finding: PsA was associated with a 31.9% increased risk for Crohn’s disease (odds ratio [OR] 1.319; P < .001) and genetically predicted Crohn’s disease was linked to a 44.8% higher risk for PsA (OR 1.448; P = .001).

Study details: Findings are from a bidirectional 2-sample mendelian randomization study including 4510 patients with psoriasis, 1637 patients with PsA, and 212,242 control individuals along with 657 patients with Crohn’s disease, 2251 patients with ulcerative colitis, and 210,300 control individuals.

Disclosures: This study did not report the source of funding. The authors declared no conflicts of interest.

Source: Sun Y et al. The causal relationship between psoriasis, psoriatic arthritis, and inflammatory bowel diseases. Sci Rep. 2022;12:20526 (Nov 28). Doi: 10.1038/s41598-022-24872-5

Recommended Reading

Serum calprotectin: A promising biomarker in PsA
Psoriatic Arthritis ICYMI
Treg cells and serum Treg-associated cytokines play an important role in PsA pathogenesis
Psoriatic Arthritis ICYMI
Wide variance described in lab monitoring of conventional synthetic DMARDs
Psoriatic Arthritis ICYMI
Skinny-label biosimilars provide substantial savings to Medicare
Psoriatic Arthritis ICYMI
Commentary: Sex differences, pregnancy, a quicker CRP test, and new drugs in PsA, December 2022
Psoriatic Arthritis ICYMI
Vaccination cuts long COVID risk for rheumatic disease patients
Psoriatic Arthritis ICYMI
Bimekizumab shows promise in PsA patients naive to bDMARD
Psoriatic Arthritis ICYMI
BNT162b2 booster dose highly recommended for PsA patients on TNF inhibitors
Psoriatic Arthritis ICYMI
Bimekizumab beneficial in PsA patients with inadequate response to or intolerance of TNFα inhibitors
Psoriatic Arthritis ICYMI
Nailfold capillary abnormalities predict PsA in patients with psoriasis
Psoriatic Arthritis ICYMI